waticlems commited on
Commit
e69cf9d
·
verified ·
1 Parent(s): a92e6a9

add biotab XML files

Browse files

downloaded from TCGA portal on June 13th, 2024

This view is limited to 50 files because it contains too many changes.   See raw diff
Files changed (50) hide show
  1. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VL.xml +154 -0
  2. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VO.xml +155 -0
  3. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VT.xml +206 -0
  4. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VV.xml +154 -0
  5. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VX.xml +153 -0
  6. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W1.xml +154 -0
  7. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W3.xml +165 -0
  8. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYF.xml +155 -0
  9. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYO.xml +154 -0
  10. biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYU.xml +155 -0
  11. biotab-xml/nationwidechildrens.org_clinical.TCGA-4L-AA1F.xml +151 -0
  12. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5737.xml +121 -0
  13. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5738.xml +153 -0
  14. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5739.xml +153 -0
  15. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5740.xml +121 -0
  16. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5741.xml +183 -0
  17. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5743.xml +184 -0
  18. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5744.xml +121 -0
  19. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5745.xml +121 -0
  20. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5746.xml +153 -0
  21. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5748.xml +121 -0
  22. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5750.xml +153 -0
  23. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5751.xml +241 -0
  24. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5752.xml +183 -0
  25. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5753.xml +121 -0
  26. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5754.xml +121 -0
  27. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5761.xml +121 -0
  28. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5762.xml +153 -0
  29. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5763.xml +153 -0
  30. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5764.xml +121 -0
  31. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5765.xml +153 -0
  32. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5766.xml +121 -0
  33. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5767.xml +153 -0
  34. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5768.xml +153 -0
  35. biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5769.xml +121 -0
  36. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5494.xml +185 -0
  37. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5495.xml +185 -0
  38. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5496.xml +186 -0
  39. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5497.xml +184 -0
  40. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5498.xml +184 -0
  41. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5499.xml +186 -0
  42. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5501.xml +185 -0
  43. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5502.xml +185 -0
  44. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5503.xml +185 -0
  45. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5504.xml +186 -0
  46. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5505.xml +155 -0
  47. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5506.xml +186 -0
  48. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5507.xml +186 -0
  49. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5508.xml +185 -0
  50. biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5509.xml +186 -0
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VL.xml ADDED
@@ -0,0 +1,154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">7E2ED8FD-7842-4722-A070-37896CF6ABD5</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516490">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516507">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516500">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516545">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18658</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">621</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216678">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VL</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VL</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">49197847-CC83-4CE1-8397-D09CEA4C4928</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516508">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516501">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516502">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">51</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516511">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516556">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217282">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516491">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3516492" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516493">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516498">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516499">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516499">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516512">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">21</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516521">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516522">NO</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516527"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516528">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516533"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516540">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516542">15</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516543">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516544">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516554"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516555"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3516513"/>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516534">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516536">T2b</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516541">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516561">0.05</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">585</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516496">6</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516494">3</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516495">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516497">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516564">NO</clin_shared:postoperative_rx_tx>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516563">NO</clin_shared:radiation_therapy>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516565"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516562">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516566">NO</nte:new_tumor_event_after_initial_treatment>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VL-F71759</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">6E1A6CED-30C0-4A4D-A550-82214C73826D</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136738">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136739">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136740"/>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136741"/>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136743">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136742"/>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">621</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136752"/>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136753"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136754"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136779">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136755">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136756"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136765"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136766"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136777"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136778"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136767"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136768"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ </prad:follow_ups>
153
+ </prad:patient>
154
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VO.xml ADDED
@@ -0,0 +1,155 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">13F0E1EF-4F73-442C-A662-9143555CBE82</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516775">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516792">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516785">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516830">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20958</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1332</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216227">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VO</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VO</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">91C0D161-2B59-4B7A-8C19-6D26DEA31849</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516793">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516786">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516787">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516796">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516841">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217001">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516776">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3516777" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516778">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516783">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516784">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516797">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">22</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516806">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516807">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">11</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516812">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516813">YES</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">84</prad:days_to_diagnostic_mri_performed>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516818">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516825">NO</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516827"/>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516828"/>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516829">R1</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516839"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516840"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516798">T1c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516819">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516823">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516826"/>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516846">0.05</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1332</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516781">6</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516779">3</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516780">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516782">4</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516849">NO</clin_shared:postoperative_rx_tx>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516848">NO</clin_shared:radiation_therapy>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3516850"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516847">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3516851">NO</nte:new_tumor_event_after_initial_treatment>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VO-F71780</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">3A8226A3-E762-4CD4-A32A-64E485053187</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136608">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136609">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136610">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136611">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136613">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136612"/>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1701</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136622"/>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136623"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136624"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136649">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4136625">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136626"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136635"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136636"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136647"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136648"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136637"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4136638"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ </prad:follow_ups>
154
+ </prad:patient>
155
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VT.xml ADDED
@@ -0,0 +1,206 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">89B056B9-2922-4AB0-A282-83A2D28DEE09</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517155">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517172">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517165">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517210">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17365</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">995</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217095">ASIAN</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VT</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">931B549F-B9F2-4E8D-83ED-FF663671883C</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517173">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517166">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517167">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">47</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517176">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3517221" xsi:nil="true"/>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216488">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517156">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517157" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517158">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517163">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517164">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517177">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">4</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517186">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517187">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">-2</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517192">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517193">YES</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">4</prad:days_to_diagnostic_mri_performed>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517198">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517205">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517207">16</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517208">2</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517209">R1</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517219"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517220"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517179">T2c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517199">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517204">T4</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517206">N1</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517226">0.05</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">995</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517161">9</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517159">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517160">5</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517162"/>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517229">YES</clin_shared:postoperative_rx_tx>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517228">YES</clin_shared:radiation_therapy>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3517230" xsi:nil="true"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517227">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517231">NO</nte:new_tumor_event_after_initial_treatment>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs>
120
+ <rx:drug>
121
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842930">NO</rx:tx_on_clinical_trial>
122
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
123
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-D64628</rx:bcr_drug_barcode>
124
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">9804256C-57A6-4DD3-9AAA-5E51F57DAA41</rx:bcr_drug_uuid>
125
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
126
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
127
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
128
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
129
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
130
+ <rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">85</rx:days_to_drug_therapy_start>
131
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">1086</rx:days_to_drug_therapy_end>
132
+ <rx:therapy_types>
133
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842933">Hormone Therapy</rx:therapy_type>
134
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
135
+ </rx:therapy_types>
136
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842931">Lupron</rx:drug_name>
137
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3842932"/>
138
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
139
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
140
+ <rx:route_of_administrations>
141
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
142
+ </rx:route_of_administrations>
143
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842938">NO</rx:therapy_ongoing>
144
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842943">Stable Disease</clin_shared:measure_of_response>
145
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">4</clin_shared:day_of_form_completion>
146
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
147
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
148
+ </rx:drug>
149
+ </rx:drugs>
150
+ <rad:radiations>
151
+ <rad:radiation>
152
+ <rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-R64625</rad:bcr_radiation_barcode>
153
+ <rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">75D9201B-00AF-41E6-BD55-F4093E8698EA</rad:bcr_radiation_uuid>
154
+ <rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">137</rad:days_to_radiation_therapy_start>
155
+ <rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">193</rad:days_to_radiation_therapy_end>
156
+ <rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842891">External</rad:radiation_type>
157
+ <rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
158
+ <rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842893">7200</rad:radiation_dosage>
159
+ <rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842894">cGy</rad:units>
160
+ <rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3842895"/>
161
+ <rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842892">Primary Tumor Field</rad:anatomic_treatment_site>
162
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
163
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
164
+ <rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842900">NO</rad:radiation_treatment_ongoing>
165
+ <rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
166
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3842905">Stable Disease</clin_shared:measure_of_response>
167
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">4</clin_shared:day_of_form_completion>
168
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
169
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
170
+ </rad:radiation>
171
+ </rad:radiations>
172
+ <prad:follow_ups>
173
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
174
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VT-F71798</clin_shared:bcr_followup_barcode>
175
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">2194A7E8-9DD7-4E55-9EF6-BACD266E1E90</clin_shared:bcr_followup_uuid>
176
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137453">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
177
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137454">NO</clin_shared:lost_follow_up>
178
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137455"/>
179
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137456"/>
180
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137458">Alive</clin_shared:vital_status>
181
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137457"/>
182
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1373</clin_shared:days_to_last_followup>
183
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
184
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137467"/>
185
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137468"/>
186
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137469"/>
187
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137529">Stable Disease</clin_shared:followup_treatment_success>
188
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137470">NO</nte:new_tumor_event_after_initial_treatment>
189
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
190
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137471"/>
191
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137480"/>
192
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137481"/>
193
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137527"/>
194
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137528"/>
195
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
196
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
197
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
198
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137482"/>
199
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137483"/>
200
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
201
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
202
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
203
+ </follow_up_v1.0:follow_up>
204
+ </prad:follow_ups>
205
+ </prad:patient>
206
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VV.xml ADDED
@@ -0,0 +1,154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">456E0D8B-3028-41AC-B751-075FA99E7A91</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517250">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517267">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517260">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517305">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19065</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4216771"/>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VV</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VV</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">75A7AFB5-66D5-47E3-8A8A-3E3A1E749A96</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517268">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517261">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517262">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">52</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517271">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517316">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216166">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517251">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517252" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517253">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517258">Right</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517259">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517259">Middle</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517272">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">167</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517281">Equivocal</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517282">YES</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">29</prad:days_to_diagnostic_computed_tomography_performed>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517287">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517288">YES</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">204</prad:days_to_diagnostic_mri_performed>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517293">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517300">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517302">16</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517303">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517304">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517314"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517315"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517274">T2b</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517294">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517296">T2b</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517301">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517321">0.05</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">560</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517256">6</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517254">3</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517255">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517257">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517324">NO</clin_shared:postoperative_rx_tx>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517323">NO</clin_shared:radiation_therapy>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517325"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517322">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517326">NO</nte:new_tumor_event_after_initial_treatment>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VV-F71800</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FC901101-A4AB-466A-BBE9-8ADC403ECF47</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137533">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137534">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137535"/>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137536"/>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137538">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137537"/>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137547"/>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137548"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137549"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137574">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137550">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137551"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137560"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137561"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137572"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137573"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137562"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137563"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ </prad:follow_ups>
153
+ </prad:patient>
154
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8VX.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">04172A7C-2055-4D30-A222-7DBF32487EB6</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517440">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517457">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517450">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517495">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25904</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1033</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216403">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VX</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8VX</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">942F1788-D977-4AC0-A177-659F9D4CD077</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517458">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517451">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517452">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">70</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517461">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517506">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217187">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517441">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517442" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517443">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517448">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517449">Middle</prad:tumor_level>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517462">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">32</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517471">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517472">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">32</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517477">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517478">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">89</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517483">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517490">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517492">16</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517493">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517494">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517504"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517505"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517464">T2c</shared_stage:clinical_T>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517484">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517488">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517491">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517511">0.05</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1033</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517446">8</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517444">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517445">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517447"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517514">NO</clin_shared:postoperative_rx_tx>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517513">NO</clin_shared:radiation_therapy>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517515"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517512">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517516">NO</nte:new_tumor_event_after_initial_treatment>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8VX-F71804</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">24877403-12D1-40B7-8F7F-67714B8EAC8A</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137672">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137673">NO</clin_shared:lost_follow_up>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137674"/>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137675"/>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137677">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137676"/>
129
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1378</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137686"/>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137687"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137688"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137713">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137689">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137690"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137699"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137700"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137711"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137712"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137701"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137702"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W1.xml ADDED
@@ -0,0 +1,154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">FA6BCFE6-BB77-4097-B610-AF2F2494EAB8</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517820">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517837">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517830">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517875">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19964</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">112</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216482">ASIAN</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W1</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8W1</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">F5319FD5-BEAE-4CA8-8F42-45FCA5E6A2D2</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517838">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517831">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517832">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517841">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517886"/>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217091">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517821">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3517822" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517823">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517828">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517829">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517829">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517842">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">27</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517851">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517852">NO</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517857"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517858">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517863"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517870">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517872">12</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517873">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517874">R1</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517884"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517885"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517843">T1c</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517864">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517868">T3a</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517871">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517891">0.05</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">-122</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517826">7</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517824">4</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517825">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517827"/>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517894"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3517893"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3517895"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517892">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3517896">NO</nte:new_tumor_event_after_initial_treatment>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W1-F71808</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8ECE00DC-877F-4CF3-9B4E-99CD261A68A6</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137852">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137853">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137854"/>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137855"/>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137857">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137856"/>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">112</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137866"/>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137867"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137868"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="4137893" xsi:nil="true"/>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4137869">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137870"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137879"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137880"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137891"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137892"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137881"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4137882"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ </prad:follow_ups>
153
+ </prad:patient>
154
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-A8W3.xml ADDED
@@ -0,0 +1,165 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">9C2D1395-B78A-4290-91AA-0C6887C0172E</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">389.51.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518010">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518027">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518020">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518065">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25557</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">771</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217183">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W3</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8W3</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5A790086-4887-4D2B-9C28-0FDD5DD1F1FB</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518028">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518021">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518022">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">69</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518031">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3518076" xsi:nil="true"/>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216400">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518011">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3518012" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518013">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518018">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518019">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518032">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">13</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518041">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518042">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">13</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518047">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518048">YES</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">-14</prad:days_to_diagnostic_mri_performed>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518053">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518060">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518062">3</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518063">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518064">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518074"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518075"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518034">T2b</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518054">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518058">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518061">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518081">.36</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">771</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518016">9</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518014">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518015">5</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518017"/>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518084">NO</clin_shared:postoperative_rx_tx>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518083">NO</clin_shared:radiation_therapy>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518085"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518082">YES</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">198</prad:days_to_first_biochemical_recurrence>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518086">YES</nte:new_tumor_event_after_initial_treatment>
118
+ <prad_nte:new_tumor_event>
119
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3518087">Biochemical evidence of disease</nte:new_neoplasm_event_type>
120
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
121
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518092"/>
122
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518093"/>
123
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518094"/>
124
+ <prad_shared:type_of_progression_after_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518095"/>
125
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518100"/>
126
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3518101"/>
127
+ </prad_nte:new_tumor_event>
128
+ </prad_nte:new_tumor_events>
129
+ <rx:drugs/>
130
+ <rad:radiations/>
131
+ <prad:follow_ups>
132
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
133
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-A8W3-F71815</clin_shared:bcr_followup_barcode>
134
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">50CC6A78-1576-40D2-AC0B-EEDFE398939F</clin_shared:bcr_followup_uuid>
135
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138074">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
136
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138075">NO</clin_shared:lost_follow_up>
137
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138076"/>
138
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138077"/>
139
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138079">Alive</clin_shared:vital_status>
140
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138078"/>
141
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">863</clin_shared:days_to_last_followup>
142
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
143
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138088"/>
144
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138089"/>
145
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138090"/>
146
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138136"/>
147
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138109">YES</nte:new_tumor_event_after_initial_treatment>
148
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">198</nte:days_to_new_tumor_event_after_initial_treatment>
149
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138110">Biochemical evidence of disease</nte:new_neoplasm_event_type>
150
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138119"/>
151
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138120"/>
152
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138134"/>
153
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4138135"/>
154
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">198</follow_up_v1.0:days_to_first_biochemical_recurrence>
155
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
156
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
157
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138121"/>
158
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138122"/>
159
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
160
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
161
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
162
+ </follow_up_v1.0:follow_up>
163
+ </prad:follow_ups>
164
+ </prad:patient>
165
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYF.xml ADDED
@@ -0,0 +1,155 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">E7A83F64-D527-4BC2-ABF7-9435FFE54E3E</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696290">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696307">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696300">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696345">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20866</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">972</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216315">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYF</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYF</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">490E84ED-3C02-4593-990E-ADE5C109DF44</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696308">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696301">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696302">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696311">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696356">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216940">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696291">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3696292" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696293">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696298">Right</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696299">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696312">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696321"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696322">NO</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696327"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696328">YES</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">186</prad:days_to_diagnostic_mri_performed>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696333">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696340">NO</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696342"/>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696343"/>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696344">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696354"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696355"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696313">T1c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696334">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696338">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696341"/>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696361">.05</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">972</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696296">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696294">3</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696295">4</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3696297"/>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696364">NO</clin_shared:postoperative_rx_tx>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696363">NO</clin_shared:radiation_therapy>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696365">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696362">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3696366">NO</nte:new_tumor_event_after_initial_treatment>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYF-F71830</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">F16D469B-D8E9-4719-BAF8-5C0BFBD68D3C</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138879">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138880">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138881"/>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138882"/>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138937">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138883"/>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1364</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138946"/>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138947"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138948"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138973">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4138949">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138950"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138959"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138960"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138971"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138972"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138961"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4138962"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ </prad:follow_ups>
154
+ </prad:patient>
155
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYO.xml ADDED
@@ -0,0 +1,154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">0581FFE4-B58F-4219-82A0-7A34D573E254</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699909">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699926">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699919">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699964">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21183</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">922</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216397">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYO</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYO</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8C0D361F-EAAB-4768-90F2-B7A610E2BBB1</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699927">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699920">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699921">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699930">2011</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699975">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217188">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699910">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3699911" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699912">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699917">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699918">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699918">Middle</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699931">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699940"/>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699941">NO</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699946"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699947">YES</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">180</prad:days_to_diagnostic_mri_performed>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699952">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699959">NO</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699961"/>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699962"/>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699963">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699973"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699974"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699932">T1c</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699953">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699955">T2c</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699960"/>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699980">.05</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">922</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699915">6</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699913">3</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699914">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3699916"/>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699983">NO</clin_shared:postoperative_rx_tx>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699982">NO</clin_shared:radiation_therapy>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699984">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699981">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3699985">NO</nte:new_tumor_event_after_initial_treatment>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYO-F71840</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">9380832C-00A8-4C1A-A816-28B764D77FA1</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139345">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139346">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139347"/>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139348"/>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139350">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139349"/>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1272</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139359"/>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139360"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139361"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139386">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139362">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139363"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139372"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139373"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139384"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139385"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139374"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139375"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ </prad:follow_ups>
153
+ </prad:patient>
154
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-2A-AAYU.xml ADDED
@@ -0,0 +1,155 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">6509FB0F-B2DD-414A-A3AB-1E448422D27B</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701200">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701217">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701210">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701255">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20582</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">615</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216826">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYU</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">2A</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AAYU</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">AA1A3A43-2F9C-456C-BA74-81C29B9801CB</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701218">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701211">NO</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701212">YES</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701221">2012</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701266">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216050">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701201">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3701202" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701203">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701208">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701209">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701222">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701231"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701232">NO</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701237"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701238">YES</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">52</prad:days_to_diagnostic_mri_performed>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701243">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701250">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701252">28</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701253">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701254">R1</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701264"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3701265"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701223">T1c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701244">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701248">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701251">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701271">.05</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">269</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701206">6</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701204">3</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701205">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701207">4</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701274">NO</clin_shared:postoperative_rx_tx>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701273">NO</clin_shared:radiation_therapy>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="3701275" xsi:nil="true"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701272">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3701276">NO</nte:new_tumor_event_after_initial_treatment>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-2A-AAYU-F71848</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7A3178ED-1B80-4624-AD64-F48A46BC6C4B</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139648">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139649">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139650"/>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139651"/>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139653">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139652"/>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">615</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139662"/>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139663"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139664"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4139707"/>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4139676">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139677"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139686"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139687"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139705"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139706"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139688"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4139689"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ </prad:follow_ups>
154
+ </prad:patient>
155
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-4L-AA1F.xml ADDED
@@ -0,0 +1,151 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">92B5D7DB-2B0F-452C-ACE5-0C1D7D009D46</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">429.43.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969002">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969019">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969012">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969057">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23665</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">350</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4217344">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-4L-AA1F</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">4L</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">AA1F</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">47ABCD03-C6FF-4777-AC26-F880474092FF</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969020">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8140/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969013">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969014">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969023">2013</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969068">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4216564">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">14</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969003">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3969004" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969005">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969010">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969011">Middle</prad:tumor_level>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969024">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">0</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969033">Abnormal (not related to prostate cancer)</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969034">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">4</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969039">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969040">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">5</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969045">Extraprostatic Extension Localized (e.g. seminal vesicles)</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969052">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969054">4</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969055">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969056">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969066"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969067"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969026">T2c</shared_stage:clinical_T>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969046">M1a</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969050">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969053">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969101">3.5</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">350</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969008">8</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969006">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969007">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3969009"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969131">YES</clin_shared:postoperative_rx_tx>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969130">NO</clin_shared:radiation_therapy>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969132">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969102">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3969137">NO</nte:new_tumor_event_after_initial_treatment>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs>
118
+ <rx:drug>
119
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985925">NO</rx:tx_on_clinical_trial>
120
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
121
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-4L-AA1F-D67927</rx:bcr_drug_barcode>
122
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">00CA7115-7773-4773-9AC4-FFCCD1CCF33B</rx:bcr_drug_uuid>
123
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
124
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
126
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
127
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
128
+ <rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">15</rx:days_to_drug_therapy_start>
129
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
130
+ <rx:therapy_types>
131
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985928">Hormone Therapy</rx:therapy_type>
132
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
133
+ </rx:therapy_types>
134
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985926">Zoladex</rx:drug_name>
135
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3985927"/>
136
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
137
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
138
+ <rx:route_of_administrations>
139
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
140
+ </rx:route_of_administrations>
141
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3985933">YES</rx:therapy_ongoing>
142
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3985938" xsi:nil="true"/>
143
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:day_of_form_completion>
144
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
145
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
146
+ </rx:drug>
147
+ </rx:drugs>
148
+ <rad:radiations/>
149
+ <prad:follow_ups/>
150
+ </prad:patient>
151
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5737.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">0FE3727F-29E5-4498-B028-DF7525AB8259</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827619">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827635">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827629">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827670">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26753</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">91</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827633">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5737</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5737</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">4f9f1fce-d96e-407b-a873-56129985aece</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827640">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827688">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827689">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">73</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827638">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827677">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827634">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827617">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827616">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827618">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827620">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827621" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827622">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827627">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827628"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827639">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">91</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827648">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827649">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">91</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827653">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827654">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">91</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827658">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827665">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827667">8</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827668">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827669">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827678"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827679"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827641"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827659">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827661">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827666">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827683">14.69</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Discrepancy" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827625">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827623">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827624">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827626"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827684">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5738.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">A8CEBDF0-643F-428E-8B0D-996D15FAD25D</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826793">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826809">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826803">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826844">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26329</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">212</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826807">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5738</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5738</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5828401b-0901-4a73-9d0c-1e85d3431475</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826814">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826862">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826863">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826812">2006</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826851">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826808">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826791">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826790">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826792">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826794">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826795" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826796"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826801">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826802"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826813">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826822"/>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826823">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826827"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826828">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826832"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826839">NO</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826841"/>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826842"/>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826843">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826852"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826853"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826815"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826833">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1826835"/>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826840"/>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826857">0.01</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">195</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826799">6</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826797">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826798">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826800">4</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826858">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5738-F28982</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">b795c2c5-c509-4ba5-92ed-b0ea8df8ebf7</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777672">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777673">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777674">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777676">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777675">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">212</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777683">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777684"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777685"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777706">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777686">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777687"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777694"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777695"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777704"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777705"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777696"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777697"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777670">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777669">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777671">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5739.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">6C4F20AE-407F-489E-8680-5E46643FB777</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826565">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826581">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826575">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826616">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23953</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826579">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5739</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5739</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">79601d90-b198-4b94-b60f-4cff329c7a10</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826586">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826634">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826635">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826584">2006</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826623">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826580">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826563">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826562">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826564">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826566">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826567" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826568">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826573">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826574"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826585">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826594"/>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826595">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826599"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826600">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826604"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826611">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826613">8</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826614">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826615">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826624"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826625"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826587"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826605">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826609">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826612">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826629">0.02</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">586</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826571">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826569">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826570">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826572"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826630">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5739-F28977</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7265f7ed-c47f-4bc0-8772-95ac505b493b</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777520">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777521">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777522">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777524">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777523">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">671</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777531">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777532"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777533"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777554">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777534">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777535"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777542"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777543"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777552"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777553"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777544"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777545"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777518">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777517">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777519">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5740.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">60A1E979-CE4C-4FB0-9254-00C5873B09FC</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826489">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826505">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826499">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826540">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20880</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826503">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5740</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5740</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">cd113dc4-915a-47d2-bce0-9dba915a9d29</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826510">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826558">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826559">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826508">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826547">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826504">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826487">21</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826486">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826488">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826490">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826491" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826492"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826497">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826498"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826509">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826518">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826519">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826523"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826524">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">31</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826528">No Evidence of Extraprostatic Extension</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826535">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826537">4</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826538">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826539">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826548"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826549"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826511"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826529">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826531">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826536">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826553">1.6</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Discrepancy" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826495">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826493">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826494">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826496"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826554">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5741.xml ADDED
@@ -0,0 +1,183 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">4DA4B1F8-9C51-44B8-B02F-98656B2F020C</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828412">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828428">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828422">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828463">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20759</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">395</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828426">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5741</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">b3bf57d4-e31a-4740-b438-fa826fb79550</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828433">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828481">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828482">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828431">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828470">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828427">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828410">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828409">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828411">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828413">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828414" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828415">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828420">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828421"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828432">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828441">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828442">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828446">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828447">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828451"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828458">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828460">5</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828461">1</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828462">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828471"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828472"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828434"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828452">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828456">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828459">N1</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828476">0.02</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">339</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828418">9</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828416">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828417">5</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828419"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828477">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs>
118
+ <rx:drug>
119
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256041">NO</rx:tx_on_clinical_trial>
120
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
121
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741-D37729</rx:bcr_drug_barcode>
122
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">614689F1-AD81-4EDE-A7ED-BEC1E836A7DC</rx:bcr_drug_uuid>
123
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
124
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
126
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
127
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
128
+ <rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">61</rx:days_to_drug_therapy_start>
129
+ <rx:days_to_drug_therapy_end precision="month" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">334</rx:days_to_drug_therapy_end>
130
+ <rx:therapy_types>
131
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256044">Hormone Therapy</rx:therapy_type>
132
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
133
+ </rx:therapy_types>
134
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256042">Leuprorelin</rx:drug_name>
135
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2256043"/>
136
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
137
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
138
+ <rx:route_of_administrations>
139
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
140
+ </rx:route_of_administrations>
141
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256049">NO</rx:therapy_ongoing>
142
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256054">Complete Response</clin_shared:measure_of_response>
143
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
144
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
145
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
146
+ </rx:drug>
147
+ </rx:drugs>
148
+ <rad:radiations/>
149
+ <prad:follow_ups>
150
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
151
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5741-F29006</clin_shared:bcr_followup_barcode>
152
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">50d50d4b-61fb-4fdb-a345-2c2441524f1c</clin_shared:bcr_followup_uuid>
153
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778550">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
154
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
155
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778551">YES</clin_shared:radiation_therapy>
156
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778552">YES</clin_shared:postoperative_rx_tx>
157
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778554">Alive</clin_shared:vital_status>
158
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778553">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
159
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">395</clin_shared:days_to_last_followup>
160
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
161
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778561">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
162
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778562"/>
163
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778563"/>
164
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778584">Complete Remission/Response</clin_shared:followup_treatment_success>
165
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778564">NO</nte:new_tumor_event_after_initial_treatment>
166
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
167
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778565"/>
168
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778572"/>
169
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778573"/>
170
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778582"/>
171
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778583"/>
172
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
173
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
174
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
175
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778574"/>
176
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778575"/>
177
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778548">15</clin_shared:day_of_form_completion>
178
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778547">2</clin_shared:month_of_form_completion>
179
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778549">2012</clin_shared:year_of_form_completion>
180
+ </follow_up_v1.0:follow_up>
181
+ </prad:follow_ups>
182
+ </prad:patient>
183
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5743.xml ADDED
@@ -0,0 +1,184 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">4633F6B7-27ED-435E-ABFC-608D0091A2CA</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828075">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828091">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828085">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828126">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24321</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">425</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828089">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5743</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">2dee4bd8-b00e-4f8a-bfea-5d8d1a068202</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828096">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828144">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828145">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828094">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828133">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828090">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828073">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828072">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828074">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828076">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828077" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828078">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828083">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828084"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828095">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">29</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828104">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828105">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">29</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828109">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828110">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828114"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828121">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828123">1</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828124">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828125">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828134"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828135"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828097"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828115">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828117">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828122">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828139">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">394</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828081">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828079">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828080">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828082"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828140">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743-F29001</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">d0ad1d26-d82c-46e5-a36c-cf0f037c6749</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778368">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778369">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778370">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778372">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778371">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">425</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778379">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778380"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778381"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778402">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778382">YES</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">425</nte:days_to_new_tumor_event_after_initial_treatment>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778383">New Primary Tumor</nte:new_neoplasm_event_type>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778390"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778391"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778400">NO</nte:additional_radiation_therapy>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778401">NO</nte:additional_pharmaceutical_therapy>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778392"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778393"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778366">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778365">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778367">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
152
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5743-F29000</clin_shared:bcr_followup_barcode>
153
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">36503065-1d92-471a-8aae-eaf90b5c7b42</clin_shared:bcr_followup_uuid>
154
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778318">Additional New Tumor Event</clin_shared:followup_case_report_form_submission_reason>
155
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
156
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778350"/>
157
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778351"/>
158
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778359">Alive</clin_shared:vital_status>
159
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778352"/>
160
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000"/>
161
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
162
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778360"/>
163
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778361"/>
164
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778362"/>
165
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778349">Complete Remission/Response</clin_shared:followup_treatment_success>
166
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778329">YES</nte:new_tumor_event_after_initial_treatment>
167
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">425</nte:days_to_new_tumor_event_after_initial_treatment>
168
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778330">New Primary Tumor</nte:new_neoplasm_event_type>
169
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778337"/>
170
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778338"/>
171
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778347">NO</nte:additional_radiation_therapy>
172
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778348">NO</nte:additional_pharmaceutical_therapy>
173
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
174
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
176
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778339"/>
177
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778340"/>
178
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778316">20</clin_shared:day_of_form_completion>
179
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778315">2</clin_shared:month_of_form_completion>
180
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778317">2012</clin_shared:year_of_form_completion>
181
+ </follow_up_v1.0:follow_up>
182
+ </prad:follow_ups>
183
+ </prad:patient>
184
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5744.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">7B247DEF-FF0F-4209-A133-977C0203AC96</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827999">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828015">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828009">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828050">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23621</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">60</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828013">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5744</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5744</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">4e76de8e-cb0d-4b83-8ab4-53bc67a7a9d3</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828020">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828068">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828069">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828018">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828057">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828014">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827997">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827996">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827998">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828000">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828001" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828002">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828007">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828008"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828019">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">60</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828028">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828029">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">60</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828033">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828034">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828038"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828045">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828047">3</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828048">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828049">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828058"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828059"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828021"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828039">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828041">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828046">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828063">9.63</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">48</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828005">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828003">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828004">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828006">5</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828064">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5745.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">B5EADF40-6F5D-4B30-80CF-2775BC3FDD4B</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828597">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828613">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828607">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828648">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24837</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">91</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828611">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5745</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5745</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">ac67d0df-7dc0-4a1a-8b47-beec9b94de86</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828618">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828666">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828667">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828616">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828655">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828612">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828595">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828594">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828596">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828598">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828599" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828600">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828605"/>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828606"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828617">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">91</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828626">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828627">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828631"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828632">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828636"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828643">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828645">5</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828646">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828647">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828656"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828657"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828619"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828637">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828641">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828644">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828661">4.3</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">84</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828603">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828601">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828602">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828604"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828662">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5746.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">7A49E2D9-0EE0-43AD-A0CA-838F02D536E9</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827467">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827483">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827477">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827518">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20941</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827481">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5746</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5746</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">618272c0-c2ed-4bfb-bb4b-404f0987f822</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827488">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827536">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827537">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827486">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827525">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827482">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827465">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827464">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827466">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827468">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827469" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827470"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827475">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827476"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827487">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">59</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827496">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827497">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">59</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827501">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827502">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827506"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827513">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827515">2</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827516">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827517">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827526"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827527"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827489"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827507">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827509">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827514">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827531">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">693</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827473">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827471">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827472">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827474"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827532">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5746-F28996</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">90a1a1cd-057d-45ea-b417-3ba252ddbb98</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778176">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778177">YES</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778178">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778180">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778179">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778187">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778188"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778189"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778210">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778190">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778191"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778198"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778199"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778208"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778209"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778200"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778201"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778174">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778173">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778175">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5748.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">353E756A-54D5-4ADC-BD4C-F66EBB2F4E92</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826413">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826429">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826423">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826464">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23649</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826427">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5748</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5748</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0af98331-9305-41e9-af55-30390016d65e</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826434">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826482">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826483">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">64</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826432">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826471">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826428">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826411">21</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826410">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826412">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826414">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826415" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826416"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826421">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826422"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826433">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826442"/>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826443">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826447"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826448">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826452"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826459">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826461">2</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826462">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826463">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826472"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826473"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826435"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826453"/>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826457">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826460">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826477"/>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Not Available" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000"/>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826419">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826417">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826418">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826420"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826478"/>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5750.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">CAE0D4A3-44DE-4C6C-8AEE-56CB225D98B2</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828151">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828167">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828161">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828202">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26389</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">396</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828165">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5750</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5750</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">dc40cf49-b208-4f59-b5f0-cfbdd02970b2</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828172">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828220">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828221">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828170">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828209">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828166">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828149">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828148">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828150">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828152">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828153" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828154">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828159">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828160"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828171">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828180">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828181">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828185">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828186">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828190"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828197">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828199">7</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828200">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828201">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828210"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828211"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828173"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828191">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828193">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828198">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828215">0.02</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">337</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828157">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828155">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828156">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828158"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828216">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5750-F29002</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">e1cba76b-72f8-4f39-adc2-c7defb3f66dc</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778408">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778409">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778410">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778412">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778411">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">396</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778419">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778420"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778421"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778442">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778422">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778423"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778430"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778431"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778440"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778441"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778432"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778433"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778406">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778405">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778407">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5751.xml ADDED
@@ -0,0 +1,241 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">C877133B-25FA-4BC1-8244-4C533FFEC1C5</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826717">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826733">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826727">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826768">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24957</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1065</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826731">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5751</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">721e76d0-4b1d-4e78-adb8-1344b8030062</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826738">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826786">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826787">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826736">2006</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826775">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826732">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826715">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826714">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826716">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826718">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826719" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826720">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826725">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826726"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826737">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">92</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826746">Equivocal</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826747">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">92</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826751">Equivocal</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826752">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">92</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826756">Equivocal</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826763">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826765">3</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826766">1</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826767">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826776"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826777"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826739"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826757">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826762">T4</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826764">N1</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826781">0.01</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1004</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826723">10</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826721">5</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826722">5</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826724"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826782">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs>
118
+ <rx:drug>
119
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256024">NO</rx:tx_on_clinical_trial>
120
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
121
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37727</rx:bcr_drug_barcode>
122
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7C511DDA-B637-4FC2-B97F-E300227673B3</rx:bcr_drug_uuid>
123
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
124
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
126
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
127
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
128
+ <rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">122</rx:days_to_drug_therapy_start>
129
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
130
+ <rx:therapy_types>
131
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256027">Hormone Therapy</rx:therapy_type>
132
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
133
+ </rx:therapy_types>
134
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256025">Bicalutamide</rx:drug_name>
135
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256026">n/a</rx:clinical_trail_drug_classification>
136
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
137
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
138
+ <rx:route_of_administrations>
139
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
140
+ </rx:route_of_administrations>
141
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256032">YES</rx:therapy_ongoing>
142
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256037" xsi:nil="true"/>
143
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
144
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
145
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
146
+ </rx:drug>
147
+ <rx:drug>
148
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256058">NO</rx:tx_on_clinical_trial>
149
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
150
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37730</rx:bcr_drug_barcode>
151
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">96ED97DC-8704-4EE2-A453-C2836B029E24</rx:bcr_drug_uuid>
152
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
153
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
154
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
155
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
156
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
157
+ <rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">122</rx:days_to_drug_therapy_start>
158
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
159
+ <rx:therapy_types>
160
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256061">Hormone Therapy</rx:therapy_type>
161
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
162
+ </rx:therapy_types>
163
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256059">Leuprorelin</rx:drug_name>
164
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256060">n/a</rx:clinical_trail_drug_classification>
165
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
166
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
167
+ <rx:route_of_administrations>
168
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
169
+ </rx:route_of_administrations>
170
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256066">YES</rx:therapy_ongoing>
171
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256071" xsi:nil="true"/>
172
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
173
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
174
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
175
+ </rx:drug>
176
+ <rx:drug>
177
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256075">NO</rx:tx_on_clinical_trial>
178
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
179
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-D37731</rx:bcr_drug_barcode>
180
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">F97A29DB-3655-45F0-AFD3-E4CFBC126F63</rx:bcr_drug_uuid>
181
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
182
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
183
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
184
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
185
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
186
+ <rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">245</rx:days_to_drug_therapy_start>
187
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
188
+ <rx:therapy_types>
189
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256078">Ancillary</rx:therapy_type>
190
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
191
+ </rx:therapy_types>
192
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256076">Zoledronic acid</rx:drug_name>
193
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256077">n/a</rx:clinical_trail_drug_classification>
194
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
195
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
196
+ <rx:route_of_administrations>
197
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
198
+ </rx:route_of_administrations>
199
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256083">YES</rx:therapy_ongoing>
200
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256088" xsi:nil="true"/>
201
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
202
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
203
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
204
+ </rx:drug>
205
+ </rx:drugs>
206
+ <rad:radiations/>
207
+ <prad:follow_ups>
208
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
209
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5751-F28978</clin_shared:bcr_followup_barcode>
210
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">348b5cd7-410b-428c-9ffd-424783054f08</clin_shared:bcr_followup_uuid>
211
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777560">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
212
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
213
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777561">NO</clin_shared:radiation_therapy>
214
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777562">YES</clin_shared:postoperative_rx_tx>
215
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777564">Alive</clin_shared:vital_status>
216
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777563">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
217
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1065</clin_shared:days_to_last_followup>
218
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
219
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777571">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
220
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777572"/>
221
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777573"/>
222
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777594">Stable Disease</clin_shared:followup_treatment_success>
223
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777574">YES</nte:new_tumor_event_after_initial_treatment>
224
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="month" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000">365</nte:days_to_new_tumor_event_after_initial_treatment>
225
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777575">Distant Metastasis</nte:new_neoplasm_event_type>
226
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777582">Bone</nte:new_neoplasm_event_occurrence_anatomic_site>
227
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777583"/>
228
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777592">NO</nte:additional_radiation_therapy>
229
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777593">YES</nte:additional_pharmaceutical_therapy>
230
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
231
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
232
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
233
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777584">YES</prad_shared:tumor_progression_post_ht>
234
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777585">Distant Metastasis</follow_up_v1.0:type_ofprogression_of_disease_ht>
235
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777558">15</clin_shared:day_of_form_completion>
236
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777557">2</clin_shared:month_of_form_completion>
237
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777559">2012</clin_shared:year_of_form_completion>
238
+ </follow_up_v1.0:follow_up>
239
+ </prad:follow_ups>
240
+ </prad:patient>
241
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5752.xml ADDED
@@ -0,0 +1,183 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">F926AF4E-078C-47BE-B164-FDAEB75FA5A4</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827087">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827103">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827097">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827138">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24290</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">943</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827101">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5752</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">d8f56d75-51ab-4a86-a502-c86e1dcd1eff</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827108">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827156">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827157">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827106">2006</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827145">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827102">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827085">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827084">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827086">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827088">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827089" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827090">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827095">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827096"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827107">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827116">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827117">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827121">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827122">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827126"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827133">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827135">9</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827136">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827137">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827146"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827147"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827109"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827127">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827131">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827134">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827151">0.02</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">868</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827093">8</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827091">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827092">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827094"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827152">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs>
118
+ <rx:drug>
119
+ <rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256092">NO</rx:tx_on_clinical_trial>
120
+ <rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
121
+ <rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752-D37732</rx:bcr_drug_barcode>
122
+ <rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">69D28B65-0490-48ED-8428-097F98AD9B75</rx:bcr_drug_uuid>
123
+ <rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
124
+ <rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
126
+ <rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
127
+ <rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
128
+ <rx:days_to_drug_therapy_start precision="month" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">578</rx:days_to_drug_therapy_start>
129
+ <rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
130
+ <rx:therapy_types>
131
+ <rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256095">Hormone Therapy</rx:therapy_type>
132
+ <rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
133
+ </rx:therapy_types>
134
+ <rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256093">Leuprorelin</rx:drug_name>
135
+ <rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256094">n/a</rx:clinical_trail_drug_classification>
136
+ <clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
137
+ <clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
138
+ <rx:route_of_administrations>
139
+ <rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
140
+ </rx:route_of_administrations>
141
+ <rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2256100">YES</rx:therapy_ongoing>
142
+ <clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="2256105" xsi:nil="true"/>
143
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
144
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
145
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2012</clin_shared:year_of_form_completion>
146
+ </rx:drug>
147
+ </rx:drugs>
148
+ <rad:radiations/>
149
+ <prad:follow_ups>
150
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
151
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5752-F28987</clin_shared:bcr_followup_barcode>
152
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">762f37b3-0606-4d9b-8022-4be93e8aabab</clin_shared:bcr_followup_uuid>
153
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777882">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
154
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
155
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777883">YES</clin_shared:radiation_therapy>
156
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777884">YES</clin_shared:postoperative_rx_tx>
157
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777886">Alive</clin_shared:vital_status>
158
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777885">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
159
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">943</clin_shared:days_to_last_followup>
160
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
161
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777893">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
162
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777894"/>
163
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777895"/>
164
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777916">Complete Remission/Response</clin_shared:followup_treatment_success>
165
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777896">NO</nte:new_tumor_event_after_initial_treatment>
166
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
167
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777897"/>
168
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777904"/>
169
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777905"/>
170
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777914"/>
171
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777915"/>
172
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
173
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
174
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
175
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777906"/>
176
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777907"/>
177
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777880">15</clin_shared:day_of_form_completion>
178
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777879">2</clin_shared:month_of_form_completion>
179
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777881">2012</clin_shared:year_of_form_completion>
180
+ </follow_up_v1.0:follow_up>
181
+ </prad:follow_ups>
182
+ </prad:patient>
183
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5753.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">FEB4DFE7-01C0-4E2D-8637-3E2E182C0DA1</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828858">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828874">Yes</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828868">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828909">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-25780</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828872">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5753</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5753</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">928c48a0-68ee-4e28-ae83-9832e52850ca</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828879">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828927">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828928">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">70</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828877">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828916">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828873">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828856">21</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828855">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828857">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828859">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828860" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828861">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828866">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828867"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828878">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828887">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828888">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828892">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828893">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828897"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828904">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828906">10</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828907">3</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828908">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828917"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828918"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828880"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828898">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828902">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828905">N1</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828922">4.53</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">31</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828864">9</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828862">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828863">5</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828865"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828923">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5754.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">3149A4D9-127F-497E-900C-E90EDB912804</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828782">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828798">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828792">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828833">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23803</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">62</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828796">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5754</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5754</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0aad0abd-750a-400d-a34f-491da996d46c</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828803">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828851">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828852">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828801">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828840">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828797">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828780">21</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828779">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828781">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828783">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828784" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828785">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828790">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828791"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828802">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">62</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828811">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828812">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">62</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828816">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828817">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828821"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828828">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828830">11</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828831">3</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828832">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828841"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828842"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828804"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828822">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828826">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828829">N1</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828846">37.36</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">62</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828788">9</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828786">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828787">5</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828789">3</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828847">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5761.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">970B70BC-052F-4986-B3CA-AEB24FFB3893</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827543">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827559">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827553">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827594">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22433</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">28</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827557">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5761</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5761</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">854a481b-71a2-4f23-80aa-e91e9f4069b1</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827564">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827612">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827613">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">61</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827562">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827601">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827558">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827541">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827540">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827542">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827544">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827545" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827546">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827551">Left</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827552"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827563">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">28</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827572">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827573">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">28</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827577">Equivocal</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827578">YES</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="month" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Completed" preferred_name="days_to_mri" display_order="46" cde_ver="1.000">28</prad:days_to_diagnostic_mri_performed>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827582">Equivocal</prad:diagnostic_mri_result>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827589">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827591">5</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827592">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827593">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827602"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827603"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827565"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827583">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827587">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827590">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827607">8.49</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">39</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827549">9</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827547">5</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827548">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827550">3</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827608">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5762.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">5D306570-B39B-43A0-985D-DBE73B9EC095</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826641">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826657">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826651">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826692">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22068</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1339</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826655">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5762</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5762</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">d4ffafdc-ee83-43df-aa3b-7326503c6438</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826662">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826710">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826711">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">60</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826660">2005</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1826699" xsi:nil="true"/>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826656">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826639">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826638">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826640">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826642">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1826643" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826644">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826649">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826650"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826661">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">92</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826670">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826671">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">92</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826675">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826676">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826680"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826687">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826689">7</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826690">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826691">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826700"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826701"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1826663"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826681">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826685">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826688">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826705">.01</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1313</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826647">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826645">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826646">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1826648"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1826706">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5762-F28975</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">bdae05b3-8281-4ba4-8d6d-4616d304fef9</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777458">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777459">YES</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777460">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777462">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777461">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1339</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="1777469" xsi:nil="true"/>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777470"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777471"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777492">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777472">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777473"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777480"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777481"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777490"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777491"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777482"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777483"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777456">14</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777455">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777457">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5763.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">C39F0889-6590-4F8B-B741-506D1689CD49</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828488">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828504">Yes</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828498">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828539">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24380</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">365</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828502">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5763</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5763</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">18e79a01-07a2-4cd5-b700-71d41724e041</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828509">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828557">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828558">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828507">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828546">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828503">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828486">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828485">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828487">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828489">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828490" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828491">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828496">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828497"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828508">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">0</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828517">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828518">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">0</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828522">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828523">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828527"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828534">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828536">5</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828537">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828538">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828547"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828548"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828510"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828528">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828532">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828535">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828552">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">360</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828494">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828492">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828493">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828495"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828553">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5763-F28974</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8bc71c57-3d08-445c-ace6-5bd3e201446b</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777418">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777419">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777420">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777422">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777421">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">365</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777429">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777430"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777431"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777452">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777432">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777433"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777440"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777441"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777450"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777451"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777442"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1777443"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777416">14</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777415">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1777417">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5764.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">74160F0D-C476-4AB9-9CF9-72821ED1A18D</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828673">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828689">Yes</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828683">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828724">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24257</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828687">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5764</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5764</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">ed73f136-42e8-4100-b432-d10370d07e8b</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828694">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828742">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828743">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828692">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828731">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828688">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828671">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828670">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828672">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828674">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1828675" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828676">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828681">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828682"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828693">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828702">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828703">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828707">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828708">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828712"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828719">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828721">8</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828722">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828723">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828732"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828733"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1828695"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828713">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828717">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828720">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828737">13.95</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">29</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828679">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828677">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828678">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1828680"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1828738">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5765.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">B39AC952-235B-48E6-9F58-10B0A317F7FC</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827391">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827407">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827401">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827442">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="year" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20364</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">700</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827405">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5765</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5765</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">716eb429-d7af-4d4f-bd8d-afcff1a323ee</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827412">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827460">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827461">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="year" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827410">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827449">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827406">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827389">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827388">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827390">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827392">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827393" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827394"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827399">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827400"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827411">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="year" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827420">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827421">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="year" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827425">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827426">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827430"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827437">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827439">7</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827440">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827441">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827450"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827451"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827413"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827431">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827435">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827438">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827455">0.02</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="year" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">694</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827397">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827395">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827396">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827398"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827456">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5765-F28995</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">a35e8791-c35a-4c44-831c-0466098def97</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778136">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778137">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778138">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778140">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778139">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="year" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">700</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778147">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778148"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778149"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778170">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778150">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778151"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778158"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778159"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778168"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778169"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778160"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778161"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778134">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778133">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778135">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5766.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">990F4717-1DD9-42E3-9C0E-53582306CD04</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827771">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827787">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827781">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827822">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20392</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">31</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827785">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5766</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5766</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">a5c77ab6-6e98-4a3d-81c8-f3d5fabd31d2</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827792">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827840">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827841">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827790">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827829">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827786">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827769">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827768">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827770">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827772">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827773" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827774">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827779">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827780"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827791">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827800">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827801">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827805">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827806">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827810"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827817">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827819">4</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827820">1</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827821">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827830"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827831"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827793"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827811">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827815">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827818">N1</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827835">13.9</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">39</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827777">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827775">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827776">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827778"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827836">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5767.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">62B44FD0-AC8C-4A20-ACF3-D610C83155C8</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">108.76.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827847">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827863">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827857">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827898">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24287</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">458</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827861">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5767</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5767</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8dc53431-44ab-485e-b4e6-c3d06509506d</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827868">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827916">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827917">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">66</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827866">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827905">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827862">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827845">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827844">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827846">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827848">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827849" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827850">Peripheral Zone</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827855">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827856"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827867">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827876"/>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827877">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827881"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827882">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827886"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827893">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827895">19</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827896">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827897">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827906"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827907"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827869"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827887">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827889">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827894">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827911">0.04</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">377</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827853">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827851">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827852">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827854"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827912">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5767-F28999</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">3f4b8d5e-9c1d-4120-afe3-758234fbbc6b</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778278">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778279">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778280">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778282">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778281">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">458</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778289">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778290"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778291"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778312">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778292">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778293"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778300"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778301"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778310"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778311"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778302"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778303"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778276">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778275">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778277">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5768.xml ADDED
@@ -0,0 +1,153 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">7874749D-16DE-4D1E-8E52-F734E4B4EA97</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827695">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827711">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827705">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827746">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-26480</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827709">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5768</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5768</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">f6c61a22-a711-416d-9e65-6a1b957e5b2e</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827716">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827764">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827765">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">72</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827714">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827753">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827710">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827693">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827692">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827694">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827696">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827697" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827698">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827703">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827704"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827715">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">30</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827724">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827725">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">30</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827729">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827730">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827734"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827741">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827743">16</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827744">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827745">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827754"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827755"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827717"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827735">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827739">T3a</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827742">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827759">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">634</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827701">6</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827699">2</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827700">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827702">3</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827760">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5768-F28998</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">d9b4ec26-42ca-4305-9906-1b29416d423c</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778238">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778239">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778240">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778242">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778241">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">731</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778249">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778250"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778251"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778272">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778252">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778253"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778260"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778261"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778270"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778271"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778262"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1778263"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778236">15</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778235">2</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1778237">2012</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ </prad:follow_ups>
152
+ </prad:patient>
153
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-CH-5769.xml ADDED
@@ -0,0 +1,121 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">97F1CB56-E9EE-4499-A207-9E542C1BD7B7</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827923">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827939">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827933">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827974">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17807</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">62</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827937">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-CH-5769</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">CH</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5769</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">a7b76662-8380-4f35-9307-99c0acacb904</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827944">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827992">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827993">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">48</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827942">2007</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827981">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827938">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827921">16</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827920">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827922">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827924">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1827925" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827926"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827931">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827932"/>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827943">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="month" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">62</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827952">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827953">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="month" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">62</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827957">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827958">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827962"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827969">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827971">8</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827972">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827973">R1</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827982"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827983"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1827945"/>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827963">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827967">T3b</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827970">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827987">11.16</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">60</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827929">9</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827927">5</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827928">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1827930"/>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1827988">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups/>
120
+ </prad:patient>
121
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5494.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">2CF48C9F-C247-47F1-9553-E40D538FF87A</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819080">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819096">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819090">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819131">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18596</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">378</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819094">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5494</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819101">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819253">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819254">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819099">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819138">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819095">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805659">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805658">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805660">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819081">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1819082" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1819083"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819088">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819089">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819089">Middle</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819100">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819109"/>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819110"/>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819114"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819115"/>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819119"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819126">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819128">17</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819129">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819130">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819139"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819140"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819103">T2a</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819120">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819124">T3a</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819127">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819248"/>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">184</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819086">7</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819084">4</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819085">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819087">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819249">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494-F46196</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">8BB308D6-BD5D-4A5E-BBD3-9401DC5E6044</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757076">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757077">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757078">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757079">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757081">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757080">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">826</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757090">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757091"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757092"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757117">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757093">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757094"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757103"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757104"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757115"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757116"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757105"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757106"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5494-F71910</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">95A5F4AC-25DD-4FAB-A814-CE49A444E0AA</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142019">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142020">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142021">NO</clin_shared:radiation_therapy>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142022">NO</clin_shared:postoperative_rx_tx>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142024">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142023">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1477</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142033">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142034"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142035"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142060">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142036">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142037"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142046"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142047"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142058"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142059"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142048"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142049"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5495.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">793C267C-7319-405C-B81E-C2672D7FFC7F</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819597">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819613">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819607">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819648">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24904</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">606</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819611">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5495</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">962dd3d5-8501-4658-8cb9-2424b476124c</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819618">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819672">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819673">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">68</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819616">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819655">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819612">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819518">29</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819517">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819519">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819598">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1819599" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1819600"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819605">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819606">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819606">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819617">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">26</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819626">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819627">NO</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819631"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819632">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819636"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819643">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819645">18</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819646">1</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819647">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819656"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1819657"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819619">T1c</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819637">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819641">T3b</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819644">N1</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819667">0.13</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">606</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819603">8</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819601">5</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819602">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819604">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1819668">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495-F46197</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">BDDE4025-238B-40A9-BCBC-9892909359FA</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757121">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757122">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757123">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757124">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757126">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757125">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1007</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757135">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757136"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757137"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757162">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757138">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757139"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757148"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757149"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757160"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757161"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757150"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757151"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5495-F71913</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">645F9163-A5B3-40E9-8594-437AB1E4A245</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142112">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142113">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142114">NO</clin_shared:radiation_therapy>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142115">NO</clin_shared:postoperative_rx_tx>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142117">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142116">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1760</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142126">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142127"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142128"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142159">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142129">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142130"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142139"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142140"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142157"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142158"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142141"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142142"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5496.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">AC08AF68-E22C-4DE9-8DAA-A717D1DE4DD4</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820768">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820784">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820778">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820819">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21897</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820782">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5496</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">6755c231-355f-4cc3-85f1-6306c7f5d44b</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820789">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820855">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820856">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">59</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820787">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820826">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820783">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820700">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820699">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820701">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820769">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1820770" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820771">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820776">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820777">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820788">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">15</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820797">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820798">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">15</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820802">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820803">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820807"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820814">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820816">26</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820817">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820818">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820827"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1820828"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820790">T1c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820808">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820810">T2c</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820815">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820850">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">595</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820774">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820772">3</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820773">4</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820775">4</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1820851">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496-F46198</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C458C599-0391-4932-85C6-D1709F8306A6</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757166">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757167">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757168">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757169">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757171">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757170">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757180">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757181"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757182"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757207">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757183">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757184"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757193"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757194"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757205"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757206"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757195"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757196"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5496-F60309</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">11FC2DD4-B17C-44B5-9CC6-3BDE16AD446E</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634322">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634323">YES</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634324"/>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634325"/>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634327"/>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634326"/>
162
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">595</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634336">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634337"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634338"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634363">Complete Remission/Response</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3634339"/>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634340"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634349"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634350"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634361"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634362"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634351"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634352"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5497.xml ADDED
@@ -0,0 +1,184 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">F525BF7C-A40B-4ECE-9F9F-9E64B34BFDDC</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821302">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821318">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821312">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821353">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-17523</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821316">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5497</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">dee02265-d8dd-4379-ae08-72d72b03a570</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821323">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821559">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821560">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">47</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821321">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821360">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821317">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821152">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821151">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821153">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821303">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1821304" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821305">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821310">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821311">Middle</prad:tumor_level>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821322">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821331"/>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821332">NO</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821336"/>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821337">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821341"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821348">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821350">10</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821351">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821352">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821361"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821362"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821325">T2c</shared_stage:clinical_T>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821342">M0</shared_stage:clinical_M>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821344">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821349">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821554">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">204</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821308">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821306">3</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821307">4</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821309">3</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821555">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497-F46199</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">680F390D-3704-4B35-98D4-FF11E3FD0BD0</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757211">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757212">NO</clin_shared:lost_follow_up>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757213">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757214">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757216">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757215">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757225">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757226"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757227"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757252">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757228">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757229"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757238"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757239"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757250"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757251"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757240"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757241"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
152
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5497-F60311</clin_shared:bcr_followup_barcode>
153
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">58F1853F-A9FD-4CF7-830D-096A80579A7E</clin_shared:bcr_followup_uuid>
154
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634462">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
155
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634463">YES</clin_shared:lost_follow_up>
156
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634464"/>
157
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634465"/>
158
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634467"/>
159
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634466"/>
160
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">405</clin_shared:days_to_last_followup>
161
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
162
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634476">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
163
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634477"/>
164
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634478"/>
165
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634503">Complete Remission/Response</clin_shared:followup_treatment_success>
166
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3634479"/>
167
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
168
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634480"/>
169
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634489"/>
170
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634490"/>
171
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634501"/>
172
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634502"/>
173
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
174
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
176
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634491"/>
177
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634492"/>
178
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
179
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
180
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
181
+ </follow_up_v1.0:follow_up>
182
+ </prad:follow_ups>
183
+ </prad:patient>
184
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5498.xml ADDED
@@ -0,0 +1,184 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">A9918CDB-80EA-4025-84C4-0018666236C4</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821764">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821780">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821774">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821815">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20472</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">537</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821778">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5498</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">79ec7468-9aaf-4bb0-94c7-72be4f497868</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821785">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821833">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821834">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">56</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821783">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821822">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821779">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821762">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821761">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821763">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821765">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1821766" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821767">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821772">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821773">Middle</prad:tumor_level>
55
+ </prad:tumor_levels>
56
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821784">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
57
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">12</prad:days_to_bone_scan_performed>
58
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821793">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
59
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821794">YES</prad:diagnostic_ct_abd_pelvis_performed>
60
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">12</prad:days_to_diagnostic_computed_tomography_performed>
61
+ <prad:diagnostic_ct_abd_pelvis_results>
62
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821798">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
63
+ </prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821799">NO</prad:diagnostic_mri_performed>
65
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
66
+ <prad:diagnostic_mri_results>
67
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821803"/>
68
+ </prad:diagnostic_mri_results>
69
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821810">YES</prad:lymphnodes_examined>
70
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821812">26</prad:number_of_lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821813">0</prad:number_of_lymphnodes_positive_by_he>
72
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821814">R0</clin_shared:residual_tumor>
73
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821823"/>
74
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821824"/>
75
+ <shared_stage:stage_event system="AJCC">
76
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
77
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:tnm_categories>
80
+ <shared_stage:clinical_categories>
81
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821787">T2c</shared_stage:clinical_T>
82
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
83
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1821804"/>
84
+ </shared_stage:clinical_categories>
85
+ <shared_stage:pathologic_categories>
86
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821806">T2c</shared_stage:pathologic_T>
87
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821811">N0</shared_stage:pathologic_N>
88
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
89
+ </shared_stage:pathologic_categories>
90
+ </shared_stage:tnm_categories>
91
+ <shared_stage:psa>
92
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821828">0.1</shared_stage:psa_value>
93
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">537</shared_stage:days_to_psa>
94
+ </shared_stage:psa>
95
+ <shared_stage:gleason_grading>
96
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821770">7</shared_stage:gleason_score>
97
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821768">4</shared_stage:primary_pattern>
98
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821769">3</shared_stage:secondary_pattern>
99
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821771">3</shared_stage:tertiary_pattern>
100
+ </shared_stage:gleason_grading>
101
+ <shared_stage:ann_arbor>
102
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
103
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ </shared_stage:ann_arbor>
105
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ </shared_stage:stage_event>
109
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
110
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1821829">NO</prad:biochemical_recurrence>
113
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
114
+ <prad_nte:new_tumor_events>
115
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
116
+ </prad_nte:new_tumor_events>
117
+ <rx:drugs/>
118
+ <rad:radiations/>
119
+ <prad:follow_ups>
120
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
121
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498-F46200</clin_shared:bcr_followup_barcode>
122
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C0E97F6E-6B21-4761-887A-06D59D419638</clin_shared:bcr_followup_uuid>
123
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757256">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
124
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757257">NO</clin_shared:lost_follow_up>
125
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757258">NO</clin_shared:radiation_therapy>
126
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757259">NO</clin_shared:postoperative_rx_tx>
127
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757261">Alive</clin_shared:vital_status>
128
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757260">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
129
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">906</clin_shared:days_to_last_followup>
130
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
131
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757270">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
132
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757271"/>
133
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757272"/>
134
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757297">Complete Remission/Response</clin_shared:followup_treatment_success>
135
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757273">NO</nte:new_tumor_event_after_initial_treatment>
136
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
137
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757274"/>
138
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757283"/>
139
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757284"/>
140
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757295"/>
141
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757296"/>
142
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
143
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
145
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757285"/>
146
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757286"/>
147
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
148
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
149
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
150
+ </follow_up_v1.0:follow_up>
151
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
152
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5498-F71919</clin_shared:bcr_followup_barcode>
153
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">40E1D852-8D43-4FB2-9FFB-21E2D103D19D</clin_shared:bcr_followup_uuid>
154
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142259">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
155
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142260">NO</clin_shared:lost_follow_up>
156
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142261">NO</clin_shared:radiation_therapy>
157
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142262">NO</clin_shared:postoperative_rx_tx>
158
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142264">Alive</clin_shared:vital_status>
159
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142263">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
160
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1720</clin_shared:days_to_last_followup>
161
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
162
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142273">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
163
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142274"/>
164
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142275"/>
165
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142300">Complete Remission/Response</clin_shared:followup_treatment_success>
166
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142276">NO</nte:new_tumor_event_after_initial_treatment>
167
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
168
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142277"/>
169
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142286"/>
170
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142287"/>
171
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142298"/>
172
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142299"/>
173
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
174
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
176
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142288"/>
177
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142289"/>
178
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
179
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
180
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
181
+ </follow_up_v1.0:follow_up>
182
+ </prad:follow_ups>
183
+ </prad:patient>
184
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5499.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">56753EEA-2AA1-4742-A299-49E315BC3584</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822029">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822045">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822039">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822080">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-22286</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">533</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822043">ASIAN</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5499</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">fd1aa612-df86-4d48-892d-2acebd76ea96</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822050">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822098">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822099">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">61</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822048">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822087">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822044">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822027">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822026">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822028">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822030">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822031" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822032">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822037">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822038">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822049">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822058"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822059"/>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822063"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822064"/>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822068"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822075">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822077">19</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822078">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822079">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822088"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822089"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822052">T2b</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822069">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822073">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822076">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822093">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">533</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822035">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822033">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822034">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822036">3</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822094">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499-F46201</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">5687A1AE-AD09-447E-88EA-1F13ADA4A0FB</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757301">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757302">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757303">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757304">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757306">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757305">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">533</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757315">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757316"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757317"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757342">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757318">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757319"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757328"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757329"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757340"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757341"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757330"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757331"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5499-F60312</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C4FC4D67-0767-43BC-A337-060C8263FCB7</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634517">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634518">NO</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634519">NO</clin_shared:radiation_therapy>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634520">NO</clin_shared:postoperative_rx_tx>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634522">Alive</clin_shared:vital_status>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634521">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
162
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1415</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634531">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634532"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634533"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634558">Complete Remission/Response</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634534">NO</nte:new_tumor_event_after_initial_treatment>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634535"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634544"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634545"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634556"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634557"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634546"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634547"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5501.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">82E8C87D-5FE1-44E9-8B0B-016BB9946DED</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822210">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822226">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822220">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822261">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-20409</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">729</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822224">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5501</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">8df0c1e8-966c-4f46-ad15-fae9e745a32e</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822231">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822279">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822280">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">55</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822229">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822268">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822225">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822182">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822181">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822183">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822211">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822212" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822213">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822218">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822219">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822219">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822230">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">9</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822239">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822240">YES</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">9</prad:days_to_diagnostic_computed_tomography_performed>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822244">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822245">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822249"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822256">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822258">11</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822259">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822260">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822269"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822270"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822233">T2b</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822250">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822254">T3b</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822257">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822274">0.1</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">729</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822216">7</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822214">4</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822215">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822217">5</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822275">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501-F46202</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">888320E4-BDAE-4601-8105-9B8669942A38</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757346">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757347">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757348">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757349">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757351">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757350">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">937</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757360">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757361"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757362"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757387">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757363">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757364"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757373"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757374"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757385"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757386"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757375"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757376"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5501-F60313</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">32D86851-E857-4DF2-AAEF-2489FAA38F43</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634604">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634605">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634606"/>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634607"/>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634609">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634608"/>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1365</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634618">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634619"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634620"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634645">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3634621">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634622"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634631"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634632"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634643"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634644"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634633"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3634634"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5502.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">28CB850D-2299-4372-8FF0-636A0E247570</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822722">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822738">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822732">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822773">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18447</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">245</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822736"/>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5502</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">48e83a4c-c602-494a-80cd-e2f4b4dd701e</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822743">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822791">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822792">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822741">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822780">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822737"/>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822720">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822719">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822721">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822723">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1822724" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822725">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822730">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822731">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822731">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822742">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">7</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822751">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822752">YES</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">7</prad:days_to_diagnostic_computed_tomography_performed>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822756">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822757">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822761"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822768">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822770">11</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822771">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822772">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822781"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1822782"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822745">T2c</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822762">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822764">T2c</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822769">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822786">0.1</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">603</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822728">7</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822726">4</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822727">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822729">3</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1822787">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502-F46203</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FBF12F0D-ED5E-4A8B-8264-3A4563C2CA4E</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757391">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757392">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757393">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757394">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757396">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757395">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">800</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757405">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757406"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757407"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757432">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757408">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757409"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757418"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757419"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757430"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757431"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757420"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757421"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5502-F71921</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">CB9EF708-2D68-4BBC-96E3-A92B637940EE</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142373">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142374">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142375">NO</clin_shared:radiation_therapy>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142376">NO</clin_shared:postoperative_rx_tx>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142382">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142377">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1171</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142391">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142392"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142393"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142418">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142394">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142395"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142404"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142405"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142416"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142417"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142406"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142407"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5503.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">B565F73C-B169-41A9-83BC-B6B56DC78127</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823257">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823273">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823267">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823308">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-18395</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">530</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823271">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5503</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">aa252f78-ebf3-42f9-86af-bb6e57345706</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823278">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823370">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823371">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">50</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823276">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823315">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823272">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823105">30</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823104">3</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823106">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823258">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1823259" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823260">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823265">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823266">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823266">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823277">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">31</prad:days_to_bone_scan_performed>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823286">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823287">YES</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">31</prad:days_to_diagnostic_computed_tomography_performed>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823291">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823292">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823296"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823303">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823305">21</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823306">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823307">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823316"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1823317"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823280">T2b</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823297">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823301">T3a</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823304">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823365">0.1</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">530</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823263">8</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823261">5</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823262">3</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823264">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1823366">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503-F46204</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">E09A254F-1C32-44B5-A628-DD29C5E27C3E</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757436">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757437">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757438">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757439">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757441">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757440">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">716</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757450">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757451"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757452"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757477">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757453">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757454"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757463"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757464"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757475"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757476"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757465"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757466"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5503-F60037</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">26A25DCA-6024-4434-9890-198114671D32</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621189">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621190">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621191">NO</clin_shared:radiation_therapy>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621192">NO</clin_shared:postoperative_rx_tx>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621194">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621193">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1391</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621203">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621204"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621205"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621230">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3621206">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621207"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621216"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621217"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621228"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621229"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621218"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3621219"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">28</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5504.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">A828FB32-08EA-4738-87C0-1810723EE639</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833711">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833727">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833721">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833762">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24072</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">229</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833725">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5504</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e1c3d1bd-cf8f-4fa4-ac8e-bf9e54f7aad4</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833732">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833824">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833825">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833730">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833769">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833726">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833709">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833708">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833710">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833712">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1833713" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833714">Overlapping / Multiple Zones</prad:zone_of_origin>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833719">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833720">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833731">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">25</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833740">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833741">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">25</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833745">Extraprostatic Extension (regional lymphadenopathy)[e.g. cN1]</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833746">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833750"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833757">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833759">18</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833760">1</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833761">R1</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833770"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1833771"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833734">T2c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833751">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833755">T3a</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833758">N1</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833819">1.0</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">77</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833717">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833715">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833716">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833718">5</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1833820">YES</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">77</prad:days_to_first_biochemical_recurrence>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504-F46205</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">E27457FB-2F9A-40CB-8FCA-21AD85F9E33D</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757481">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757482">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757483">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757484">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757486">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757485">Progressive Disease</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">880</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757495">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757496"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757497"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757522">Progressive Disease</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757498">YES</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757499">Biochemical evidence of disease</nte:new_neoplasm_event_type>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757508"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757509"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757520">NO</nte:additional_radiation_therapy>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757521">NO</nte:additional_pharmaceutical_therapy>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000">77</follow_up_v1.0:days_to_first_biochemical_recurrence>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Completed" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000">736</follow_up_v1.0:days_to_second_biochemical_recurrence>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757510"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757511"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5504-F71923</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">C65034B8-D6EB-444C-A897-B9553B335E6F</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142471">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142472">NO</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142473">NO</clin_shared:radiation_therapy>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142474">NO</clin_shared:postoperative_rx_tx>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142476">Alive</clin_shared:vital_status>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142475">Progressive Disease</clin_shared:primary_therapy_outcome_success>
162
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1427</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142485">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142486"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142487"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142512">Progressive Disease</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142488">NO</nte:new_tumor_event_after_initial_treatment>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142489"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142498"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142499"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142510"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142511"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142500"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142501"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5505.xml ADDED
@@ -0,0 +1,155 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">8374339D-2BD9-45EB-891E-22A44FBF4E46</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834059">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834075">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834069">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834110">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-21164</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">448</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834073">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5505</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5505</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">1ea3b879-5451-49fb-b930-16e9b5627f18</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834080">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834128">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834129">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">57</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834078">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834117">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834074">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834032">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834031">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834033">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834060">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834061" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834062"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834067">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834068">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834079">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Completed" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000">12</prad:days_to_bone_scan_performed>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834088">Normal (no evidence of prostate cancer) [cM0]</prad:bone_scan_results>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834089">YES</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Completed" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000">12</prad:days_to_diagnostic_computed_tomography_performed>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834093">No Evidence of Extraprostatic Extension</prad:diagnostic_ct_abd_pelvis_result>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834094">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834098"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834105">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834107">24</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834108">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834109">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834118"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834119"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834081">T1c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834099">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834101">T2c</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834106">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834123">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">448</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834065">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834063">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834064">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834066">3</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834124">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5505-F46206</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7272BBED-E69B-42D3-852B-4AFC6879D750</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757526">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757527">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757528">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757529">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757531">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757530">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">922</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757540">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757541"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757542"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757567">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757543">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757544"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757553"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757554"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757565"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757566"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757555"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757556"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ </prad:follow_ups>
154
+ </prad:patient>
155
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5506.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">34D053EE-05E8-4A90-BD0F-54DEF598DDD7</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834241">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834257">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834251">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834292">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-24617</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">356</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834255">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5506</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e5e4d3b6-8e58-4dcf-8f67-a00e656a8e27</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834262">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834310">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834311">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">67</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834260">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834299">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834256">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834213">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834212">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834214">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834242">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834243" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834244"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834249">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834250">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834261">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834270"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834271">NO</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834275"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834276">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834280"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834287">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834289">7</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834290">1</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834291">RX</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834300"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834301"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834265">T3b</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834281">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834285">T3b</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834288">N1</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834305">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">356</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834247">8</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834245">5</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834246">3</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834248">4</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834306">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506-F46207</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">464D58E9-F998-4142-B43E-DEF506845044</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757571">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757572">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757573">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757574">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757576">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757575">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">827</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757585">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757586"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757587"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757612">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757588">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757589"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757598"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757599"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757610"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757611"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757600"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757601"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5506-F71924</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">9D8D5AF9-1C96-48A9-AFC3-9AD88E0AFD92</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142516">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142517">NO</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142518">NO</clin_shared:radiation_therapy>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142519">NO</clin_shared:postoperative_rx_tx>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142521">Alive</clin_shared:vital_status>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142520">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
162
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1381</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142530">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142531"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142532"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142557">Complete Remission/Response</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142533">NO</nte:new_tumor_event_after_initial_treatment>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142534"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142543"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142544"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142555"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142556"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142545"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142546"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5507.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">A5412427-7433-4D43-936C-97BD0692D9E1</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834612">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834628">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834622">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834663">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-19759</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">182</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834626">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5507</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">607200f5-df80-4f5d-90fb-fdc455a7415b</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834633">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834681">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834682">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834631">2010</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834670">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834627">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834610">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834609">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834611">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834613">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834614" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834615"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834620">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834621">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834632">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834641"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834642">NO</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834646"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834647">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834651"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834658">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834660">21</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834661">2</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834662">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834671"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834672"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834635">T2c</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834652">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834656">T3b</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834659">N1</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834676">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">182</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834618">9</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834616">4</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834617">5</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834619">4</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834677">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507-F46208</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">5A965AB0-241A-4188-9526-23359A1829F6</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757616">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757617">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757618">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757619">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757621">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757620">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">727</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757630">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757631"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757632"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757657">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757633">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757634"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757643"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757644"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757655"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757656"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757645"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757646"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5507-F71926</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">A099ED2D-CD15-4EE5-9F37-D8B9CDEA44DC</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142564">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142565">NO</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142566">NO</clin_shared:radiation_therapy>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142567">NO</clin_shared:postoperative_rx_tx>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142569">Alive</clin_shared:vital_status>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142568">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
162
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1457</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142578">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142579"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142580"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142605">Complete Remission/Response</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142581">NO</nte:new_tumor_event_after_initial_treatment>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142582"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142591"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142592"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142603"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142604"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142593"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142594"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5508.xml ADDED
@@ -0,0 +1,185 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">6F6B8E92-2C69-4623-8E99-C35B2CE0FF33</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834690">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834706">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834700">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834741">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23758</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">907</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834704">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5508</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">bd18dd01-d894-4bdd-9ce2-e25705a52a57</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834711">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834759">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834760">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834709">2008</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834748">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834705">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834688">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834687">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834689">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834691">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834692" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834693"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834698">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834699">Middle</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834699">Base</prad:tumor_level>
56
+ </prad:tumor_levels>
57
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834710">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
58
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
59
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834719"/>
60
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834720">NO</prad:diagnostic_ct_abd_pelvis_performed>
61
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
62
+ <prad:diagnostic_ct_abd_pelvis_results>
63
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834724"/>
64
+ </prad:diagnostic_ct_abd_pelvis_results>
65
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834725">NO</prad:diagnostic_mri_performed>
66
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
67
+ <prad:diagnostic_mri_results>
68
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834729"/>
69
+ </prad:diagnostic_mri_results>
70
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834736">YES</prad:lymphnodes_examined>
71
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834738">17</prad:number_of_lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834739">0</prad:number_of_lymphnodes_positive_by_he>
73
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834740">R0</clin_shared:residual_tumor>
74
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834749"/>
75
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834750"/>
76
+ <shared_stage:stage_event system="AJCC">
77
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
78
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:tnm_categories>
81
+ <shared_stage:clinical_categories>
82
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834712">T1c</shared_stage:clinical_T>
83
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
84
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834730">M0</shared_stage:clinical_M>
85
+ </shared_stage:clinical_categories>
86
+ <shared_stage:pathologic_categories>
87
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834734">T3a</shared_stage:pathologic_T>
88
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834737">N0</shared_stage:pathologic_N>
89
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
90
+ </shared_stage:pathologic_categories>
91
+ </shared_stage:tnm_categories>
92
+ <shared_stage:psa>
93
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834754">0.1</shared_stage:psa_value>
94
+ <shared_stage:days_to_psa precision="day" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">907</shared_stage:days_to_psa>
95
+ </shared_stage:psa>
96
+ <shared_stage:gleason_grading>
97
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834696">7</shared_stage:gleason_score>
98
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834694">3</shared_stage:primary_pattern>
99
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834695">4</shared_stage:secondary_pattern>
100
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834697">4</shared_stage:tertiary_pattern>
101
+ </shared_stage:gleason_grading>
102
+ <shared_stage:ann_arbor>
103
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
104
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ </shared_stage:ann_arbor>
106
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
107
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ </shared_stage:stage_event>
110
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
111
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834755">NO</prad:biochemical_recurrence>
114
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
115
+ <prad_nte:new_tumor_events>
116
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
117
+ </prad_nte:new_tumor_events>
118
+ <rx:drugs/>
119
+ <rad:radiations/>
120
+ <prad:follow_ups>
121
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
122
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508-F46209</clin_shared:bcr_followup_barcode>
123
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">FE909C1B-A3A6-40AD-929B-3266091DEACD</clin_shared:bcr_followup_uuid>
124
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757661">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
125
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757662">NO</clin_shared:lost_follow_up>
126
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757663">NO</clin_shared:radiation_therapy>
127
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757664">NO</clin_shared:postoperative_rx_tx>
128
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757666">Alive</clin_shared:vital_status>
129
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757665">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
130
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1184</clin_shared:days_to_last_followup>
131
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
132
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757675">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
133
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757676"/>
134
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757677"/>
135
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757702">Complete Remission/Response</clin_shared:followup_treatment_success>
136
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757678">NO</nte:new_tumor_event_after_initial_treatment>
137
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
138
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757679"/>
139
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757688"/>
140
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757689"/>
141
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757700"/>
142
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757701"/>
143
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
144
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
146
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757690"/>
147
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757691"/>
148
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
149
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
150
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
151
+ </follow_up_v1.0:follow_up>
152
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
153
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5508-F71929</clin_shared:bcr_followup_barcode>
154
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">B8B943A6-1B6C-47EC-9443-98CD0728338F</clin_shared:bcr_followup_uuid>
155
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142615">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
156
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142616">NO</clin_shared:lost_follow_up>
157
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142617">NO</clin_shared:radiation_therapy>
158
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142618">NO</clin_shared:postoperative_rx_tx>
159
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142620">Alive</clin_shared:vital_status>
160
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142619">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
161
+ <clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1965</clin_shared:days_to_last_followup>
162
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
163
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142629">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
164
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142630"/>
165
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142631"/>
166
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142656">Complete Remission/Response</clin_shared:followup_treatment_success>
167
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4142632">NO</nte:new_tumor_event_after_initial_treatment>
168
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
169
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142633"/>
170
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142642"/>
171
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142643"/>
172
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142654"/>
173
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142655"/>
174
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
175
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
177
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142644"/>
178
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4142645"/>
179
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
180
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:month_of_form_completion>
181
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
182
+ </follow_up_v1.0:follow_up>
183
+ </prad:follow_ups>
184
+ </prad:patient>
185
+ </prad:tcga_bcr>
biotab-xml/nationwidechildrens.org_clinical.TCGA-EJ-5509.xml ADDED
@@ -0,0 +1,186 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ <?xml version="1.0" encoding="UTF-8"?>
2
+ <prad:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/prad/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/prad/2.7/TCGA_BCR.PRAD_Clinical.xsd" schemaVersion="2.7" xmlns:prad="http://tcga.nci/bcr/xml/clinical/prad/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:prad_nte="http://tcga.nci/bcr/xml/clinical/prad/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/prad/followup/2.7/1.0" xmlns:prad_shared="http://tcga.nci/bcr/xml/clinical/prad/shared/2.7">
3
+ <admin:admin>
4
+ <admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
5
+ <admin:file_uuid xsd_ver="2.6">58E592FF-3F5F-4C41-9ED5-BABA68C685AF</admin:file_uuid>
6
+ <admin:batch_number xsd_ver="1.17">91.78.0</admin:batch_number>
7
+ <admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
8
+ <admin:disease_code xsd_ver="2.6">PRAD</admin:disease_code>
9
+ <admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
10
+ <admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
11
+ <admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
12
+ <admin:patient_withdrawal>
13
+ <admin:withdrawn>false</admin:withdrawn>
14
+ </admin:patient_withdrawal>
15
+ <admin:program xsi:nil="true" xsd_ver="2.7"/>
16
+ <admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
17
+ </admin:admin>
18
+ <prad:patient>
19
+ <admin:additional_studies/>
20
+ <clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834766">Prostate</clin_shared:tumor_tissue_site>
21
+ <shared:other_dx preferred_name="history_other_malignancy" display_order="21" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834782">No</shared:other_dx>
22
+ <shared:gender preferred_name="gender" display_order="14" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834776">MALE</shared:gender>
23
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834817">Alive</clin_shared:vital_status>
24
+ <clin_shared:days_to_birth precision="month" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="20" cde_ver="1.000">-23368</clin_shared:days_to_birth>
25
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
26
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1102</clin_shared:days_to_last_followup>
27
+ <clin_shared:race_list>
28
+ <clin_shared:race preferred_name="race" display_order="96" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834780">WHITE</clin_shared:race>
29
+ </clin_shared:race_list>
30
+ <shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509</shared:bcr_patient_barcode>
31
+ <shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">EJ</shared:tissue_source_site>
32
+ <shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5509</shared:patient_id>
33
+ <shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">13ce70a8-785c-4b59-b073-41922cb201f9</shared:bcr_patient_uuid>
34
+ <shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="22" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834787">No</shared:history_of_neoadjuvant_treatment>
35
+ <clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="82" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
36
+ <clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61.9</clin_shared:icd_o_3_site>
37
+ <clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8550/3</clin_shared:icd_o_3_histology>
38
+ <clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C61</clin_shared:icd_10>
39
+ <clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="15" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834835">YES</clin_shared:tissue_prospective_collection_indicator>
40
+ <clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="16" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834836">NO</clin_shared:tissue_retrospective_collection_indicator>
41
+ <clin_shared:days_to_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
42
+ <clin_shared:age_at_initial_pathologic_diagnosis precision="month" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">63</clin_shared:age_at_initial_pathologic_diagnosis>
43
+ <clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="25" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834785">2009</clin_shared:year_of_initial_pathologic_diagnosis>
44
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834824">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
45
+ <clin_shared:ethnicity preferred_name="ethnicity" display_order="97" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834781">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
46
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834764">2</clin_shared:day_of_form_completion>
47
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834763">4</clin_shared:month_of_form_completion>
48
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834765">2012</clin_shared:year_of_form_completion>
49
+ <shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834767">Prostate Adenocarcinoma Acinar Type</shared:histological_type>
50
+ <shared:histological_type_other preferred_name="histologic_diagnosis_other" display_order="6" cde="3124492" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1834768" xsi:nil="true"/>
51
+ <prad:zone_of_origin preferred_name="zone_of_origin" display_order="7" cde="65104" cde_ver="3.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="1834769"/>
52
+ <clin_shared:laterality preferred_name="laterality" display_order="12" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834774">Bilateral</clin_shared:laterality>
53
+ <prad:tumor_levels>
54
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Apex</prad:tumor_level>
55
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Middle</prad:tumor_level>
56
+ <prad:tumor_level preferred_name="tumor_level" display_order="13" cde="3348845" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834775">Base</prad:tumor_level>
57
+ </prad:tumor_levels>
58
+ <clin_shared:initial_pathologic_diagnosis_method preferred_name="method_initial_path_dx" display_order="9999" cde="2757941" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834786">Core needle biopsy</clin_shared:initial_pathologic_diagnosis_method>
59
+ <prad:days_to_bone_scan_performed precision="day" xsd_ver="2.4" tier="2" cde="3412936" owner="TSS" procurement_status="Not Available" preferred_name="days_to_bone_scan" display_order="34" cde_ver="1.000"/>
60
+ <prad:bone_scan_results preferred_name="bone_scan_results" display_order="35" cde="3351888" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834795"/>
61
+ <prad:diagnostic_ct_abd_pelvis_performed preferred_name="ct_scan_ab_pelvis_indicator" display_order="36" cde="3194099" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834796">NO</prad:diagnostic_ct_abd_pelvis_performed>
62
+ <prad:days_to_diagnostic_computed_tomography_performed precision="day" xsd_ver="2.4" tier="2" cde="3414503" owner="TSS" procurement_status="Not Available" preferred_name="days_to_ct_scan_ab_pelvis" display_order="40" cde_ver="1.000"/>
63
+ <prad:diagnostic_ct_abd_pelvis_results>
64
+ <prad:diagnostic_ct_abd_pelvis_result preferred_name="ct_scan_ab_pelvis_results" display_order="41" cde="3351890" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834800"/>
65
+ </prad:diagnostic_ct_abd_pelvis_results>
66
+ <prad:diagnostic_mri_performed preferred_name="" display_order="9999" cde="3607491" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834801">NO</prad:diagnostic_mri_performed>
67
+ <prad:days_to_diagnostic_mri_performed precision="day" xsd_ver="2.4" tier="2" cde="3414554" owner="TSS" procurement_status="Not Available" preferred_name="days_to_mri" display_order="46" cde_ver="1.000"/>
68
+ <prad:diagnostic_mri_results>
69
+ <prad:diagnostic_mri_result preferred_name="mri_results" display_order="47" cde="3351891" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834805"/>
70
+ </prad:diagnostic_mri_results>
71
+ <prad:lymphnodes_examined preferred_name="lymph_nodes_examined" display_order="54" cde="2200396" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834812">YES</prad:lymphnodes_examined>
72
+ <prad:number_of_lymphnodes_examined preferred_name="lymph_nodes_examined_count" display_order="56" cde="3" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834814">10</prad:number_of_lymphnodes_examined>
73
+ <prad:number_of_lymphnodes_positive_by_he preferred_name="lymph_nodes_examined_he_count" display_order="57" cde="3086388" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834815">0</prad:number_of_lymphnodes_positive_by_he>
74
+ <clin_shared:residual_tumor preferred_name="residual_tumor" display_order="58" cde="2608702" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834816">R0</clin_shared:residual_tumor>
75
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834825"/>
76
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1834826"/>
77
+ <shared_stage:stage_event system="AJCC">
78
+ <shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
79
+ <shared_stage:clinical_stage preferred_name="ajcc_clinical_tumor_stage" display_order="9999" cde="3440332" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
80
+ <shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
81
+ <shared_stage:tnm_categories>
82
+ <shared_stage:clinical_categories>
83
+ <shared_stage:clinical_T preferred_name="ajcc_tumor_clinical_ct" display_order="9999" cde="3440328" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834789">T2a</shared_stage:clinical_T>
84
+ <shared_stage:clinical_N preferred_name="ajcc_nodes_clinical_cn" display_order="9999" cde="3440330" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
85
+ <shared_stage:clinical_M preferred_name="ajcc_metastasis_clinical_cm" display_order="9999" cde="3440331" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834806">M0</shared_stage:clinical_M>
86
+ </shared_stage:clinical_categories>
87
+ <shared_stage:pathologic_categories>
88
+ <shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834808">T2c</shared_stage:pathologic_T>
89
+ <shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834813">N0</shared_stage:pathologic_N>
90
+ <shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
91
+ </shared_stage:pathologic_categories>
92
+ </shared_stage:tnm_categories>
93
+ <shared_stage:psa>
94
+ <shared_stage:psa_value preferred_name="psa_most_recent_results" display_order="75" cde="3351903" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834830">0.1</shared_stage:psa_value>
95
+ <shared_stage:days_to_psa precision="month" xsd_ver="2.6" tier="2" cde="3414608" owner="TSS" procurement_status="Completed" preferred_name="days_to_psa_most_recent" display_order="74" cde_ver="1.000">1102</shared_stage:days_to_psa>
96
+ </shared_stage:psa>
97
+ <shared_stage:gleason_grading>
98
+ <shared_stage:gleason_score preferred_name="gleason_score" display_order="10" cde="2534619" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834772">7</shared_stage:gleason_score>
99
+ <shared_stage:primary_pattern preferred_name="gleason_pattern_primary" display_order="8" cde="2534617" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834770">3</shared_stage:primary_pattern>
100
+ <shared_stage:secondary_pattern preferred_name="gleason_pattern_secondary" display_order="9" cde="2534618" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834771">4</shared_stage:secondary_pattern>
101
+ <shared_stage:tertiary_pattern preferred_name="gleason_pattern_tertiary" display_order="11" cde="2783875" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834773">3</shared_stage:tertiary_pattern>
102
+ </shared_stage:gleason_grading>
103
+ <shared_stage:ann_arbor>
104
+ <shared_stage:b_symptoms preferred_name="b_symptoms_present_indicator" display_order="9999" cde="2902402" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
105
+ <shared_stage:extranodal_involvement preferred_name="extranodal_lymphomatous_involvement" display_order="9999" cde="3364582" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
106
+ </shared_stage:ann_arbor>
107
+ <shared_stage:serum_markers preferred_name="" display_order="9999" cde="3901772" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
108
+ <shared_stage:igcccg_stage preferred_name="" display_order="9999" cde="3901822" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
109
+ <shared_stage:masaoka_stage preferred_name="" display_order="9999" cde="3952848" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
110
+ </shared_stage:stage_event>
111
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
112
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
113
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
114
+ <prad:biochemical_recurrence preferred_name="biochemical_recurrence_indicator" display_order="76" cde="3351904" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1834831">NO</prad:biochemical_recurrence>
115
+ <prad:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
116
+ <prad_nte:new_tumor_events>
117
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
118
+ </prad_nte:new_tumor_events>
119
+ <rx:drugs/>
120
+ <rad:radiations/>
121
+ <prad:follow_ups>
122
+ <follow_up_v1.0:follow_up version="1.0" sequence="1">
123
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509-F46210</clin_shared:bcr_followup_barcode>
124
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">908BE10F-7A02-4722-948E-FAF4DF8DDAC1</clin_shared:bcr_followup_uuid>
125
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757706">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
126
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757707">NO</clin_shared:lost_follow_up>
127
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757708">NO</clin_shared:radiation_therapy>
128
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757709">NO</clin_shared:postoperative_rx_tx>
129
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757711">Alive</clin_shared:vital_status>
130
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757710">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
131
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1102</clin_shared:days_to_last_followup>
132
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
133
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757720">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
134
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757721"/>
135
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757722"/>
136
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757747">Complete Remission/Response</clin_shared:followup_treatment_success>
137
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2757723">NO</nte:new_tumor_event_after_initial_treatment>
138
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
139
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757724"/>
140
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757733"/>
141
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757734"/>
142
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757745"/>
143
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757746"/>
144
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
145
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
146
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
147
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757735"/>
148
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2757736"/>
149
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
150
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
151
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
152
+ </follow_up_v1.0:follow_up>
153
+ <follow_up_v1.0:follow_up version="1.0" sequence="2">
154
+ <clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-EJ-5509-F60376</clin_shared:bcr_followup_barcode>
155
+ <clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">36B6AD0F-1CCA-486B-8474-FA95C5817FD9</clin_shared:bcr_followup_uuid>
156
+ <clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637731">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
157
+ <clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637732">NO</clin_shared:lost_follow_up>
158
+ <clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="77" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637733">NO</clin_shared:radiation_therapy>
159
+ <clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="78" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637734">NO</clin_shared:postoperative_rx_tx>
160
+ <clin_shared:vital_status preferred_name="vital_status" display_order="59" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637736">Alive</clin_shared:vital_status>
161
+ <clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="79" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637735">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
162
+ <clin_shared:days_to_last_followup precision="month" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="63" cde_ver="1.000">1464</clin_shared:days_to_last_followup>
163
+ <clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="67" cde_ver="1.000"/>
164
+ <clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="70" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637745">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
165
+ <clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="68" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637746"/>
166
+ <clin_shared:source_of_patient_death_reason preferred_name="cause_of_death_source" display_order="69" cde="2390921" cde_ver="1.000" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637747"/>
167
+ <clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="45" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637772">Complete Remission/Response</clin_shared:followup_treatment_success>
168
+ <nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="80" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3637748">NO</nte:new_tumor_event_after_initial_treatment>
169
+ <nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Applicable" preferred_name="new_tumor_event_dx_days_to" display_order="85" cde_ver="1.000"/>
170
+ <nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="81" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637749"/>
171
+ <nte:new_neoplasm_event_occurrence_anatomic_site preferred_name="new_tumor_event_site" display_order="86" cde="3108271" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637758"/>
172
+ <nte:new_neoplasm_occurrence_anatomic_site_text preferred_name="new_tumor_event_site_other" display_order="87" cde="3128033" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637759"/>
173
+ <nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="94" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637770"/>
174
+ <nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="95" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637771"/>
175
+ <follow_up_v1.0:days_to_first_biochemical_recurrence precision="day" xsd_ver="2.4" tier="2" cde="3414609" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_first" display_order="93" cde_ver="1.000"/>
176
+ <follow_up_v1.0:days_to_second_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414617" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_second" display_order="38" cde_ver="1.000"/>
177
+ <follow_up_v1.0:days_to_third_biochemical_recurrence precision="day" xsd_ver="2.5" tier="2" cde="3414621" owner="TSS" procurement_status="Not Available" preferred_name="days_to_biochemical_recurrence_third" display_order="42" cde_ver="1.000"/>
178
+ <prad_shared:tumor_progression_post_ht preferred_name="progression_after_hormone_tx" display_order="88" cde="3158820" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637760"/>
179
+ <follow_up_v1.0:type_ofprogression_of_disease_ht preferred_name="progression_after_hormone_tx_type" display_order="89" cde="3354944" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3637761"/>
180
+ <clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
181
+ <clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
182
+ <clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
183
+ </follow_up_v1.0:follow_up>
184
+ </prad:follow_ups>
185
+ </prad:patient>
186
+ </prad:tcga_bcr>